Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
New products, lab updates, and research resources delivered direct.
AOD-9604 vs MOTS-c MOTS-c is a mitochondrial-derived peptide that regulates metabolism through AMPK activation, a pathway involved in cellular energy regulation and insulin sensitivity a mechanism unrelated to both the GH axis and the fat-cell-targeted approach of AOD-9604
Side Effect Tolerance Both treatments can cause gastrointestinal side effects, particularly during the first few weeks of treatment
According to the study of Chen, IncRNA NEAT1 induces sorafenib resistance of HCC patients through repressing miR-335 expression and activation of c-Met-Akt signaling pathway (Shao et al., 2015) and the combination of HGF and c-Met inhibitors and sorefenib could improve the efficacy of the first line systemic treatment ( In conclusion, although the tivantinib phase III trial failed and the reason is not clear, the role of c-Met inhibitors in treating HCC can not be denied
Appropriate analytical documentation remains necessary
US$ 26.56
US$ 24.31
US$ 26.03
US$ 29.06
US$ 22.61
US$ 25.57
